Avita Medical | 1811094D - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Accuray USD 37.18M 567K 2024-12
Celltrion KRW 140.68B 584.31B 2025-12
Clinuvel Pharmaceuticals AUD 23.42M 6.49M 2025-12
Cochlear AUD 914.9M 454.8M 2025-12
CSL USD 5.7B 2.82B 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 47M 22.83M 2026-03
Divis Laboratories Ltd INR 20.17B 1.85B 2026-03
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Mayne Pharma AUD 103.54M 9.39M 2024-06
Medical Developments International AUD 21.61M 11.59M 2025-12
Nanosonics AUD 93.11M 45.89M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 69.59M 14.08M 2026-03
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pacific Edge NZD 22.5M 2.84M 2026-06
Paradigm Biopharmaceuticals AUD 21.85M 13.36M 2025-12
Pharma Mar EUR 42.28M 4.59M 2026-03
Polynovo AUD 68.22M 1.24M 2025-12
PYC Therapeutics AUD 33.63M 14.33M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Ramsay Health Care AUD 8.8B 83.5M 2025-12
ResMed USD 931.6M 9.09M 2026-03
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Telix Pharmaceuticals AUD 405.4M 26.29M 2025-12
Tilray USD 237.52M 17.34M 2025-09
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03